Preparation and preliminary evaluation study of [¹³¹I]iodocolchicine-gallic-AuNPs: a potential scintigraphic agent for inflammation detection

References

• Abdelaziz G, Shamsel‐Din HA, Sarhan MO, Gizawy MA. 2020. Tau protein targeting via radioiodinated azure a for brain theranostics: radiolabeling, molecular docking, in vitro and in vivo biological evaluation. J Labelled Comp Radiopharm. 63(1):33–42.
   PubMed Web of Science ®Google Scholar
• Alabed S, Cabello JB, Irving GJ, Qintar M, Burls A. 2014. Colchicine for pericarditis. Cochrane Database Syst Rev. (8):CD010652. DOI: https://doi.org/10.1002/14651858.CD010652.pub2
   Google Scholar
• Assadi M, Afrasiabi K, Nabipour I, Seyedabadi M. 2011. Nanotechnology and nuclear medicine; research and preclinical applications. Hell J Nucl Med. 14(2):149–159.
   PubMed Web of Science ®Google Scholar
• Borges A, Ferreira C, Saavedra MJ, Simões M. 2013. Antibacterial activity and mode of action of ferulic and gallic acids against pathogenic bacteria. Microb Drug Resist. 19(4):256–265.
   PubMed Web of Science ®Google Scholar
• Chanwitheesuk A, Teerawutgulrag A, Kilburn JD, Rakariyatham N. 2007. Antimicrobial gallic acid from Caesalpinia mimosoides Lamk. Food Chem. 100(3):1044–1048.
   Web of Science ®Google Scholar
• Cocco G, Chu DC, Pandolfi S. 2010. Colchicine in clinical medicine. A guide for internists. Eur J Intern Med. 21(6):503–508.
   PubMed Web of Science ®Google Scholar
• Cronstein BN, Molad Y, Reibman J, Balakhane E, Levin RI, Weissmann G. 1995. Colchicine alters the quantitative and qualitative display of selectins on endothelial cells and neutrophils. J Clin Invest. 96(2):994–1002.
   PubMed Web of Science ®Google Scholar
• Dalbeth N, Lauterio TJ, Wolfe HR. 2014. Mechanism of action of colchicine in the treatment of gout. Clin Ther. 36(10):1465–1479.
   PubMed Web of Science ®Google Scholar
• El-Kawy OA, Abdelaziz G. 2022. Preparation, characterization and evaluation of [125I]-pirarubicin: A new therapeutic agent for urinary bladder cancer with potential for use as theranostic agent. Appl Radiat Isot. 179:110007.
   PubMed Web of Science ®Google Scholar
• El-Kawy OA, Abdelaziz G, Abdel- Razek AS. 2022. Radiolabeling, characterization, and preclinical evaluation of plazomicin: a potential tracer for bacterial infection. Chem Biol Drug Des. 0:1–15.
   Google Scholar
• El-Ghareb WI, Swidan MM, Ibrahim IT, Abd El-Bary A, Tadros MI, Sakr TM. 2020. 99mTc-doxorubicin-loaded gallic acid-gold nanoparticles (99mTc-DOX-loaded GA-Au NPs) as a multifunctional theranostic agent. Int J Pharm. 586:119514.
   PubMedGoogle Scholar
• El-Kawy OA, Abdel-Razek AS, Sayed MS, Sayed MS. 2016a. Radiolabeling, biological evaluation and molecular docking of delafloxacin: a novel methicillin-resistant Staphylococcus aureus infection radiotracer. J Radioanal Nucl Chem. 308(3):1081–1088.
   Web of Science ®Google Scholar
• El-Kawy OA, Farah K. 2015. Radiocomplexation and biological evaluation of nemonoxacin in mice infected with multiresistant Staphylococcus aureus and penicillin-resistant Streptococci. J Radioanal Nucl Chem. 306(1):123–130.
   Web of Science ®Google Scholar
• El-Kawy OA, García-Horsman JA, Tuominen RK. 2016b. Labelling, molecular modelling and biological evaluation of vardenafil: a potential agent for diagnostic evaluation of erectile dysfunction. Appl Radiat Isot. 118:258–265.
   PubMed Web of Science ®Google Scholar
• El-Kawy OA, García-Horsman JA. 2017. 99mTc-roxifiban: a potential molecular imaging agent for the detection and localization of acute venous thrombosis. J Radioanal Nucl Chem. 311(3):1719–1728.
   Web of Science ®Google Scholar
• El-Kawy OA, Ibrahim IT, Farah K. 2015. Technetium-99 m labeling and evaluation of olsalazine: a novel agent for ulcerative colitis imaging. J Labelled Comp Radiopharm. 58(8):336–341.
   PubMed Web of Science ®Google Scholar
• El-Nour K, Salam E, Soliman H, Orabi A. 2017. Gold nanoparticles as a direct and rapid sensor for sensitive analytical detection of biogenic amines. Nanoscale Res Lett. 12(1):1–11.
   PubMedGoogle Scholar
• Gasparyan AY, Ayvazyan L, Yessirkepov M, Kitas GD. 2015. Colchicine as an anti-inflammatory and cardioprotective agent. Expert Opin Drug Metab Toxicol. 11(11):1781–1794.
   PubMed Web of Science ®Google Scholar
• Kim S-H, Jun C-D, Suk K, Choi B-J, Lim H, Park S, Lee SH, Shin H-Y, Kim D-K, Shin T-Y. 2006. Gallic acid inhibits histamine release and pro-inflammatory cytokine production in mast cells. Toxicol Sci. 91(1):123–131.
   PubMed Web of Science ®Google Scholar
• Król E, de Sousa Borges A, da Silva I, Polaquini CR, Regasini LO, Ferreira H, Scheffers D-J. 2015. Antibacterial activity of alkyl gallates is a combination of direct targeting of FtsZ and permeabilization of bacterial membranes. Front Microbiol. 6:390.
   PubMed Web of Science ®Google Scholar
• Maughan CN, Preston SG, Williams GR. 2015. Particulate inorganic adjuvants: recent developments and future outlook. J Pharm Pharmacol. 67(3):426–449.
   PubMed Web of Science ®Google Scholar
• Moreno-Álvarez S, Martínez-Castañón G, Niño-Martínez N, Reyes-Macías J, Patiño-Marín N, Loyola-Rodríguez J, Ruiz F. 2010. Preparation and bactericide activity of gallic acid stabilized gold nanoparticles. J Nanopart Res. 12(8):2741–2746.
   Web of Science ®Google Scholar
• Motaleb M, Selim AA, El-Tawoosy M, Sanad M, El-Hashash M. 2018. Synthesis, characterization, radiolabeling and biodistribution of a novel cyclohexane dioxime derivative as a potential candidate for tumor imaging. Int J Radiat Biol. 94(6):590–596.
   PubMed Web of Science ®Google Scholar
• Portincasa P. 2016. Colchicine, biologic agents and more for the treatment of familial mediterranean fever. The old, the new, and the rare. Curr Med Chem. 23(1):60–86.
   PubMed Web of Science ®Google Scholar
• Puri K, Suresh K, Gogtay N, Thatte U. 2009. Declaration of Helsinki, 2008: implications for stakeholders in research. J Postgrad Med. 55(2):131–134.
   PubMed Web of Science ®Google Scholar
• Rattanata N, Klaynongsruang S, Leelayuwat C, Limpaiboon T, Lulitanond A, Boonsiri P, Srichan S, Soontaranon S, Rugmai S, Daduang J. 2016. Gallic acid conjugated with gold nanoparticles: antibacterial activity and mechanism of action on foodborne pathogens. IJN. 11:3347–3356.
   Web of Science ®Google Scholar
• Sakr TM, El-Hashash M, El-Mohty A, Essa BM. 2020. 99mTc-gallic-gold nanoparticles as a new imaging platform for tumor targeting. Appl Radiat Isot. 164:109269.
   PubMed Web of Science ®Google Scholar
• Schlesinger N, Firestein BL, Brunetti L. 2020. Colchicine in COVID-19: an old drug, new use. Curr Pharmacol Rep. 6(4):137–145.
   PubMedGoogle Scholar
• Shamsel-Din HA, Gizawy MA, Abdelaziz G. 2020. Molecular docking and preliminary bioevaluation of 99m Tc-Thiadiazuron as a novel potential agent for cervical cancer imaging. J Radioanal Nucl Chem. 326(2):1375–1381.
   Web of Science ®Google Scholar
• Sutradhar KB, Amin M. 2014. Nanotechnology in cancer drug delivery and selective targeting. Int Scholar Res Not. 2014:1–12.
   Google Scholar